Trials / Completed
CompletedNCT00791960
Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting
Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting: A Randomized, Double Blind, Placebo-Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study will be to determine whether an intravenous dose of dimenhydrinate (also known as Gravol), given before the induction of spinal anesthesia, will decrease the incidence of intraoperative nausea and vomiting in patients undergoing Cesarean delivery. This medication is commonly given during and after the surgery if required, but it is not known whether a preventative dose will decrease the overall incidence of these side effects.
Detailed description
Nausea and vomiting remain one of the most common complications of Cesarean delivery. The results of this study will show whether or not we can improve our present anesthesia regimen, and improve the satisfaction of patients undergoing Cesarean deliveries, by reducing the incidence of nausea and vomiting. Our current practice is not to use any medication for preventing nausea and vomiting unless required. However, nausea and vomiting come quite fast and unexpectedly during the operation, and most of the time the medication we give does not work fast enough. We are planning to study the anti-nausea medication dimenhydrinate (commonly known as Gravol), which has been safely and widely used during pregnancy, labour and Cesarean deliveries, hoping that its use will decrease the incidence of this unpleasant occurrence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dimenhydrinate | single dose, 25mg, IV, diluted in 9.5mL normal saline. |
| OTHER | Placebo | single dose, 10 mL normal saline, IV |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-11-17
- Last updated
- 2010-03-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00791960. Inclusion in this directory is not an endorsement.